ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence-Reference-Cited by-同舟云学术

ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence

Published:2020-09-15 Issue:5 Volume:20 Page:1-1
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Sun Rongxin¹,Yang Longyan¹,Hu Yangping²,Wang Yan¹,Zhang Qiang ¹,Zhang Yuanyuan¹,Ji Zhili³,Zhao Dong¹

Affiliation:

1. Beijing Key Laboratory of Diabetes Prevention and Research, Department of Endocrinology, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, P.R. China

2. Department of Pathology, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, P.R. China

3. Department of General Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome-transmitted ANGPTL1 suppresses angiogenesis in glioblastoma by inhibiting the VEGFA/VEGFR2/Akt/eNOS pathway;Journal of Neuroimmunology;2024-02

2. Angiopoietin-Like Proteins: Cardiovascular Biology and Therapeutic Targeting for the Prevention of Cardiovascular Diseases;Canadian Journal of Cardiology;2023-12

3. Decreased circulating levels of angiopoietin – 1 (Ang-1) are associated with the presence of multinodular goiter or differentiated thyroid cancer;Surgery in Practice and Science;2023-06

4. Multi-Omics and Management of Follicular Carcinoma of the Thyroid;Biomedicines;2023-04-19

5. Case Report: A papillary thyroid microcarcinoma patient with skip lymph node metastasis and multiple distant metastasis;Frontiers in Surgery;2023-01-18